Table 2.
Frequently modulated miRNA expression in HBV related liver diseases
Clinical stage | miRNA | Genomic Location | Expression | Refs. |
---|---|---|---|---|
Chronic HBV | miR-122 | 18q21.3 | Up regulation | [67, 68] |
miR- 204 | 9q21.12 | Down regulation | [69] | |
Let7c | 21q21.1 | Up regulation | [68] | |
miR-23b | 9q22.32 | Up regulation | [68] | |
miR-150 | 19 q13.33 | Up regulation | [68] | |
Liver cirrhosis/Fibrosis | miR-29 | 7q32.3 | Down regulation | [70–73] |
miR-133a | 18q11.2 | Down regulation | [74] | |
miR-199 | 9q34.11 | up regulation | [75] | |
miR-214 5p | 1q24.3 | Up regulation | [76] | |
miR-221/222 | Xp11.3 | Up regulation | [77] | |
Hepatocellular carcinoma | (*) miR-17-92 cluster | 13q31.3 | Up regulation | [78] |
miR-21 | 17q23.2 | Up regulation | [78] | |
miR-96 | 7q32.2 | Up regulation | [79] | |
miR-375 | 2q35 | Up regulation | [80] | |
miR-92a | 5q14.3 | Up regulation | [80] | |
miR-101-1 | 1p31.3 | Down regulation | [81] | |
miR-199b | 9q34.11 | Down regulation | [81] | |
miR-244 | Xq28 | Up regulateion | [81] | |
miR-155 | 21q21.3 | Up regulateion | [82] | |
miR-122 | 18q21.3 | Down regulation | [83] | |
miR-145 | 5q32 | Down regulation | [84] | |
miR-132 | 17p13.3 | Down regulation | [85] | |
miR-34a | 1p36.22 | Down regulation | [58] | |
miR-23a | 19p13.12 | Down regulation | [86] | |
miR-148a | 7p15.2 | Down regulation | [87] | |
miR-192 | 11q13.1 | Down regulation | [88] | |
miR-125b | 11q24.1 | Down regulation | [89] | |
miR-200 | 1p36.33 | Down regulation | [90] | |
miR-602 | 9q34.3 | Up regulation | [91] |
(*) miR-17-92 cluster (miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92a-1)